SPAC589.09 Antibody

Shipped with Ice Packs
In Stock

Description

Target Protein Overview

  • The SPAC589.09 protein is a mitochondrial CRAL-TRIO domain-containing protein predicted to function in phosphatidylinositol/phosphatidylcholine-binding processes .

  • It is associated with the Paf1 complex, a transcriptional elongation factor involved in chromatin remodeling and histone modification .

  • The protein’s transcript contains conserved TTP family binding sites in its 3′-UTR, suggesting posttranscriptional regulation via RNA-binding proteins .

Transcriptional Regulation

The SPAC589.09 Antibody has been used to study the Paf1 complex’s role in modifying chromatin structure. Mutations in SPAC589.09 (e.g., G102S, Q170Stop) impair heterochromatin formation at euchromatic loci, highlighting its role in transcriptional silencing .

Cell Wall Dynamics

In studies of Sup11p depletion, SPAC589.09 was identified as part of a network regulating cell wall remodeling. Its downregulation correlates with increased glucanase expression, suggesting a link to stress-induced cell wall adaptation .

Mitochondrial Function

The antibody has been employed in Western Blot analyses to localize SPAC589.09 to mitochondrial compartments, supporting its role in lipid metabolism and membrane dynamics .

Key Research Findings

StudyKey Finding
Paf1 Complex MutagenesisSPAC589.09 mutations (G102S, Q170Stop) disrupt heterochromatin formation .
Cell Wall RemodelingSup11p depletion upregulates SPAC589.09-associated glucanases .
Posttranscriptional RegulationTTP-binding motifs in SPAC589.09’s 3′-UTR mediate mRNA stability .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC589.09 antibody; CRAL-TRIO domain-containing protein C589.09 antibody; mitochondrial antibody
Target Names
SPAC589.09
Uniprot No.

Target Background

Database Links
Subcellular Location
Mitochondrion.

Q&A

What is SPAC589.09 and why is it studied?

SPAC589.09 is a gene in Schizosaccharomyces pombe (fission yeast) that encodes a protein with significant research interest. Studies indicate it may have functional similarity to human C9orf64 (QNG1), which catalyzes the hydrolysis of queuosine 5'-phosphate, releasing the nucleobase queuine . This connection is particularly interesting as the human QNG1 protein can complement the yeast mutant SPAC589.05c, restoring Q incorporation into tRNA, suggesting conserved functions across species . Research on SPAC589.09 can provide valuable insights into fundamental cellular processes and potentially illuminate the functions of its human homologs.

What are the recommended applications for SPAC589.09 antibody?

SPAC589.09 antibody is primarily used for:

  • Western blotting (WB) - for detecting the protein in cell lysates

  • Enzyme-linked immunosorbent assay (ELISA) - for quantitative detection in solution

  • Immunoprecipitation (IP) - for isolating the protein from complex mixtures

When using these applications, it's crucial to follow the manufacturer's specific protocols. For WB applications, ensure identification of the antigen by comparison with appropriate controls and molecular weight markers. The antibody is specifically tested for reactivity with Schizosaccharomyces pombe (strain 972 / ATCC 24843), which should be considered when designing experiments .

How should SPAC589.09 antibody be stored and handled?

For optimal performance and shelf life of SPAC589.09 antibody:

  • Store at -20°C or -80°C upon receipt

  • Avoid repeated freeze-thaw cycles to maintain antibody activity and specificity

  • The antibody is typically supplied in a liquid form with preservatives (such as 0.03% Proclin 300)

  • Storage buffer often contains 50% Glycerol and 0.01M PBS at pH 7.4

  • For short-term use, aliquoting the antibody into small volumes and storing at 4°C (for up to 1 month) may be considered

Following proper storage conditions is critical for maintaining antibody performance in experimental applications .

What controls should be included when using SPAC589.09 antibody?

When designing experiments with SPAC589.09 antibody, include these essential controls:

  • Positive control: Wild-type S. pombe (strain 972 / ATCC 24843) cell lysate

  • Negative control: SPAC589.09 knockout strain of S. pombe

  • Secondary antibody-only control: Sample with only secondary antibody to check for non-specific binding

  • Isotype control: Non-specific rabbit IgG to assess background binding

  • Loading control: Detection of a housekeeping protein (e.g., S. pombe GAPDH/Spbc32f12.11) to normalize protein levels

These controls help verify antibody specificity and validate experimental results. For quantitative applications like Western blot, comparing band intensities across different samples requires proper normalization using housekeeping genes.

What is the optimal protocol for Western blotting with SPAC589.09 antibody?

Optimized Western Blot Protocol for SPAC589.09 Detection:

  • Sample Preparation:

    • Harvest S. pombe cells during logarithmic growth phase

    • Lyse cells in buffer containing protease inhibitors

    • Quantify protein using Bradford or BCA assay

  • Gel Electrophoresis:

    • Load 30-60 μg of total protein per lane

    • Use 10-12% SDS-PAGE gel for optimal separation

  • Transfer and Blocking:

    • Transfer to PVDF membrane (preferred over nitrocellulose)

    • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Antibody Incubation:

    • Dilute SPAC589.09 antibody 1:1000 in blocking buffer

    • Incubate overnight at 4°C

    • Wash 3x with TBST

    • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:50000 dilution)

  • Detection:

    • Develop using enhanced chemiluminescence (ECL) substrate

    • Expose to X-ray film or image using a digital imager

Expected results: The predicted molecular weight of SPAC589.09 protein should be verified against manufacturer's data sheet. Similar to other antibody detection systems, bands may appear at sizes different than predicted due to post-translational modifications or alternative splicing .

How can I optimize immunoprecipitation (IP) using SPAC589.09 antibody?

Optimized Immunoprecipitation Protocol:

  • Cell Lysate Preparation:

    • Harvest 10^8 S. pombe cells

    • Lyse in 1 mL IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, protease inhibitors)

    • Clear lysate by centrifugation (14,000 × g, 10 min, 4°C)

  • Pre-clearing (reduces non-specific binding):

    • Incubate lysate with 30 μL protein A/G beads for 1 hour at 4°C

    • Remove beads by centrifugation

  • Immunoprecipitation:

    • Add 2-5 μg of SPAC589.09 antibody to pre-cleared lysate

    • Incubate with gentle rotation overnight at 4°C

    • Add 50 μL protein A/G beads

    • Incubate for 3 hours at 4°C with gentle rotation

  • Washing and Elution:

    • Wash beads 4× with IP buffer

    • Elute proteins by boiling in SDS sample buffer or with an epitope-specific peptide

  • Analysis:

    • Analyze by Western blotting using the same SPAC589.09 antibody or another detection method

Based on immunoprecipitation techniques demonstrated for similar yeast proteins, this protocol should be optimized by adjusting antibody concentration and wash stringency for specific experimental conditions .

What are the considerations for using SPAC589.09 antibody in ELISA assays?

Key Considerations for ELISA with SPAC589.09 Antibody:

  • Plate Coating:

    • Use purified recombinant SPAC589.09 protein (0.5-5 μg/mL) or cell lysate (10-20 μg/mL)

    • Coat polystyrene plates in carbonate buffer (pH 9.6) overnight at 4°C

  • Antibody Concentration Optimization:

    • Perform a checkerboard titration with different antibody dilutions (1:500 to 1:10,000)

    • Create a standard curve using recombinant SPAC589.09 protein

    • Determine optimal working dilution that provides good signal-to-noise ratio

  • Detection System:

    • Use HRP-conjugated secondary antibody (anti-rabbit IgG)

    • For increased sensitivity, consider biotin-streptavidin amplification system

  • Data Validation:

    • Include standard curves with known concentrations of recombinant protein

    • Include negative controls (samples from SPAC589.09 knockout strain)

    • Calculate coefficient of variation (CV) between technical replicates (aim for <10%)

  • Troubleshooting High Background:

    • Increase blocking time or concentration (5% BSA or 5% milk in PBS)

    • Add 0.05% Tween-20 to washing buffer

    • Consider using different blocking agents (BSA vs. milk)

This methodology draws from standard ELISA protocols adapted for research antibodies and should be optimized for specific experimental conditions .

How can SPAC589.09 antibody be used to study protein-protein interactions?

Advanced Techniques for Protein-Protein Interaction Studies:

  • Co-Immunoprecipitation (Co-IP):

    • Perform IP with SPAC589.09 antibody as described earlier

    • Analyze precipitates by mass spectrometry to identify interacting partners

    • Confirm interactions by reciprocal Co-IP with antibodies against putative partners

    • Validate with controls including IP from knockout strains

  • Proximity Ligation Assay (PLA):

    • Fix cells and permeabilize using standard immunofluorescence protocols

    • Incubate with SPAC589.09 antibody and antibody against suspected interacting protein

    • Apply PLA probes and perform ligation and amplification

    • Analyze fluorescent signals using confocal microscopy

    • Quantify interaction signals per cell

  • Chromatin Immunoprecipitation (ChIP) (if SPAC589.09 has DNA-binding properties):

    • Cross-link protein-DNA complexes in vivo

    • Immunoprecipitate with SPAC589.09 antibody

    • Identify bound DNA sequences by qPCR or sequencing

  • Bimolecular Fluorescence Complementation (BiFC):

    • Create fusion constructs of SPAC589.09 and potential partners with split fluorescent protein fragments

    • Validate interactions using the antibody as a control for expression levels

These techniques leverage antibody specificity to capture and identify protein complexes under near-physiological conditions, providing insights into SPAC589.09 function within cellular pathways .

What approaches can be used to study SPAC589.09 localization in cellular compartments?

Advanced Cellular Localization Methods:

  • Immunofluorescence Microscopy:

    • Fix S. pombe cells with 4% paraformaldehyde

    • Permeabilize with 0.1% Triton X-100

    • Block with 5% BSA in PBS

    • Incubate with SPAC589.09 antibody (1:500) overnight at 4°C

    • Detect with fluorescently-labeled secondary antibody

    • Counterstain nuclei with DAPI

    • Image using confocal microscopy

  • Subcellular Fractionation with Immunoblotting:

    • Separate cellular compartments (cytoplasm, nucleus, mitochondria, etc.)

    • Prepare Western blots from each fraction

    • Probe with SPAC589.09 antibody

    • Use compartment-specific markers as controls (e.g., histone H3 for nucleus)

    • Quantify relative distribution across fractions

  • Immuno-Electron Microscopy:

    • Fix cells with glutaraldehyde and osmium tetroxide

    • Embed in resin and prepare ultrathin sections

    • Incubate with SPAC589.09 antibody

    • Detect with gold-conjugated secondary antibody

    • Visualize using transmission electron microscopy

    • Quantify gold particle distribution across cellular structures

  • Live Cell Imaging Correlation:

    • Express SPAC589.09 with fluorescent protein tag

    • Compare localization pattern with fixed-cell immunofluorescence using the antibody

    • Analyze dynamics in response to various cellular stresses

These methods provide complementary data on protein localization at different resolution levels and under various conditions .

How can SPAC589.09 antibody be utilized in studying post-translational modifications?

Methods for PTM Detection and Analysis:

  • Immunoprecipitation Followed by PTM-Specific Detection:

    • Immunoprecipitate SPAC589.09 using the antibody

    • Perform Western blotting with antibodies against specific PTMs:

      • Phosphorylation (anti-phospho-Ser/Thr/Tyr)

      • Ubiquitination (anti-ubiquitin)

      • SUMOylation (anti-SUMO)

      • Acetylation (anti-acetyl-Lys)

    • Compare band patterns under different cellular conditions

  • Mass Spectrometry Analysis of Immunoprecipitated SPAC589.09:

    • Immunoprecipitate SPAC589.09 under different conditions

    • Perform in-gel trypsin digestion

    • Analyze peptides by LC-MS/MS

    • Use database searching to identify modified peptides

    • Validate findings using PTM-specific antibodies

  • Phospho-Specific Analysis:

    • Treat cells with phosphatase inhibitors before lysis

    • Perform immunoprecipitation with SPAC589.09 antibody

    • Run samples on Phos-tag gels to separate phosphorylated species

    • Detect with SPAC589.09 antibody

    • Compare migration patterns before and after phosphatase treatment

  • PTM Dynamics Under Different Conditions:

    • Subject cells to various stresses (oxidative, nutrient deprivation, etc.)

    • Analyze changes in PTM patterns of SPAC589.09

    • Correlate modifications with protein function or localization

This methodological approach combines antibody-based purification with advanced analytical techniques to comprehensively map and functionally characterize SPAC589.09 post-translational modifications .

What are common issues with SPAC589.09 antibody in Western blotting and how can they be resolved?

Troubleshooting Western Blot Problems:

IssuePossible CausesSolutions
No signal- Insufficient protein loaded
- Poor transfer
- Inactive antibody
- Increase protein amount (60-100 µg)
- Check transfer efficiency with Ponceau S staining
- Use fresh antibody aliquot
Multiple bands- Cross-reactivity
- Protein degradation
- Post-translational modifications
- Increase antibody dilution (1:2000 or higher)
- Add protease inhibitors during extraction
- Compare with knockout control
High background- Insufficient blocking
- Excessive antibody concentration
- Poor washing
- Extend blocking time to 2 hours
- Dilute antibody further (1:5000)
- Increase wash duration and number (5 × 10 min)
Unexpected band size- Post-translational modifications
- Alternative splicing
- Experimental artifacts
- Validate with recombinant protein control
- Check literature for reported modifications
- Try different sample preparation methods

For particularly challenging detections, consider using a higher sensitivity ECL substrate or longer exposure times. The predicted molecular weight of SPAC589.09 should be compared with observed band sizes, noting that post-translational modifications may alter migration patterns .

How can I validate the specificity of SPAC589.09 antibody results?

Comprehensive Antibody Validation Strategies:

  • Genetic Validation:

    • Compare wild-type strain with SPAC589.09 deletion mutant

    • Analyze antibody reactivity in overexpression strains

    • Use CRISPR/Cas9 to tag the endogenous protein and compare detection patterns

  • Biochemical Validation:

    • Perform peptide competition assay:

      • Pre-incubate antibody with excess immunizing peptide

      • Compare signal with and without peptide competition

    • Cross-validate with a second antibody targeting a different epitope

    • Compare detection with orthogonal methods (e.g., mass spectrometry)

  • Expression Pattern Validation:

    • Compare protein levels with mRNA expression data

    • Verify expected changes in response to known stimuli

    • Confirm subcellular localization using fractionation and immunofluorescence

  • Quantitative Validation:

    • Establish linear detection range using recombinant protein standards

    • Perform dilution series of cellular extracts

    • Calculate coefficient of variation across technical replicates

This multi-faceted validation approach ensures confidence in experimental results and minimizes the risk of artifacts or misinterpretation due to antibody cross-reactivity .

How should I analyze data from experiments using SPAC589.09 antibody for comparative studies?

Data Analysis Best Practices:

  • Quantification Methods for Western Blot:

    • Use digital imaging systems rather than film for wider dynamic range

    • Define regions of interest (ROIs) consistently across all bands

    • Subtract local background from each band

    • Normalize to loading controls (e.g., GAPDH/Spbc32f12.11)

    • Express results as relative fold change compared to control samples

  • Statistical Analysis:

    • Perform at least three biological replicates

    • Test for normal distribution (Shapiro-Wilk test)

    • For normally distributed data:

      • Use t-test for two-group comparisons

      • Use ANOVA for multiple group comparisons

    • For non-normally distributed data:

      • Use Mann-Whitney or Wilcoxon tests

    • Report p-values and confidence intervals

  • Visualization Guidelines:

    • Present representative blots alongside quantification graphs

    • Include molecular weight markers on blot images

    • Use consistent scale and axis labels

    • Show individual data points in addition to means and error bars

    • Indicate statistical significance clearly

  • Reproducibility Considerations:

    • Document complete experimental conditions

    • Report antibody catalog numbers and dilutions used

    • Specify exact sample preparation methods

    • Consider using automated liquid handling for improved precision

How can SPAC589.09 antibody be used in combination with high-throughput techniques?

Integration with Advanced Genomic and Proteomic Methods:

  • ChIP-Seq (if SPAC589.09 has DNA-binding potential):

    • Perform chromatin immunoprecipitation with SPAC589.09 antibody

    • Prepare DNA libraries from immunoprecipitated material

    • Sequence using next-generation sequencing

    • Map binding sites to S. pombe genome

    • Correlate with transcriptional data using RNA-Seq

  • Proteomics Integration:

    • Immunoprecipitate SPAC589.09 protein complexes

    • Analyze by mass spectrometry

    • Identify interaction networks

    • Compare protein interactions under different conditions

    • Validate key interactions with targeted Co-IP

  • High-Content Imaging:

    • Perform immunofluorescence in 96-well format

    • Image using automated high-content microscopy

    • Analyze localization changes across genetic backgrounds

    • Conduct drug or genetic screens for modulators of localization

  • Antibody Arrays:

    • Develop custom antibody arrays including SPAC589.09 antibody

    • Analyze protein expression across multiple samples simultaneously

    • Correlate with phenotypic data

These approaches leverage the specificity of SPAC589.09 antibody for large-scale analyses, providing systems-level insights into protein function and regulation .

What are the considerations for using SPAC589.09 antibody in evolutionary studies across fungal species?

Cross-Species Applications and Evolutionary Analysis:

  • Sequence Homology Analysis:

    • Perform sequence alignment of SPAC589.09 across fungal species

    • Identify conserved epitopes targeted by the antibody

    • Predict cross-reactivity based on epitope conservation

  • Cross-Reactivity Testing:

    • Test antibody against lysates from multiple yeast species:

      • Saccharomyces cerevisiae

      • Candida albicans

      • Cryptococcus neoformans

      • Other fission yeast species

    • Compare band patterns and signal intensities

    • Confirm specificity with respective gene deletion mutants

  • Comparative Localization Studies:

    • Perform immunofluorescence across species

    • Compare subcellular distribution patterns

    • Correlate with functional conservation/divergence

  • Experimental Design for Evolutionary Studies:

    • Use consistent lysis and detection conditions across species

    • Include appropriate controls for each species

    • Normalize protein loading based on total protein rather than specific markers

    • Consider epitope accessibility differences due to protein structure variation

This methodology enables the use of SPAC589.09 antibody as a tool for comparative studies, providing insights into protein evolution and functional conservation across fungal lineages .

How can computational approaches enhance antibody-based studies of SPAC589.09?

Integration of Computational Methods with Antibody Research:

  • Epitope Prediction and Analysis:

    • Use epitope prediction algorithms to map the specific region recognized by the antibody

    • Model the 3D structure of SPAC589.09 using homology modeling

    • Predict accessibility of epitopes in native protein conformation

    • Assess potential for cross-reactivity with similar proteins

  • Network Analysis of Interacting Partners:

    • Integrate immunoprecipitation-mass spectrometry data into protein interaction networks

    • Predict functional modules using clustering algorithms

    • Identify potential functions based on guilt-by-association principles

    • Generate testable hypotheses for experimental validation

  • Quantitative Image Analysis for Localization Studies:

    • Develop custom image analysis pipelines for immunofluorescence data

    • Quantify colocalization with subcellular markers

    • Track changes in localization under different conditions

    • Apply machine learning for pattern recognition

  • Integration with Public Datasets:

    • Compare SPAC589.09 expression and localization with public transcriptomic and proteomic data

    • Correlate antibody-derived data with phenotypic information from genome-wide screens

    • Use antibody validation data to improve computational prediction of antibody specificity

These computational approaches enhance the value of antibody-derived data by providing context, predictive power, and integration with broader biological knowledge .

How might SPAC589.09 antibody be utilized in studying cellular stress responses?

Methodological Approaches for Stress Response Studies:

  • Time-Course Analysis Following Stress Induction:

    • Subject S. pombe cells to various stresses:

      • Oxidative stress (H₂O₂)

      • Heat shock

      • Nutrient deprivation

      • DNA damage (UV, MMS)

    • Collect samples at multiple time points (0, 15, 30, 60, 120 min)

    • Analyze SPAC589.09 protein levels by Western blotting

    • Determine subcellular localization changes by immunofluorescence

  • Correlation with Stress Response Pathways:

    • Compare SPAC589.09 dynamics with known stress markers

    • Analyze in strains with deletions in key stress pathway components

    • Determine if SPAC589.09 is directly regulated by stress-responsive transcription factors

  • Post-Translational Modification Changes:

    • Immunoprecipitate SPAC589.09 from stressed and unstressed cells

    • Analyze PTM changes by mass spectrometry

    • Determine functional consequences of stress-induced modifications

  • Experimental Design Considerations:

    • Use appropriate controls for each stress condition

    • Validate antibody performance under each experimental condition

    • Consider potential changes in epitope accessibility during stress responses

This systematic approach can reveal potential roles of SPAC589.09 in cellular adaptation to environmental challenges, providing insights into stress response mechanisms in fission yeast and potentially conserved pathways in higher eukaryotes .

What approaches can be used for developing improved versions of SPAC589.09 antibodies for specialized research applications?

Advanced Antibody Engineering Strategies:

  • Epitope Mapping and Refinement:

    • Use peptide arrays to precisely identify the epitope recognized

    • Design synthetic peptides representing different regions of SPAC589.09

    • Generate new antibodies against underrepresented epitopes

    • Compare performance of different epitope-targeted antibodies

  • Affinity Maturation Approaches:

    • Apply phage display technology to isolate high-affinity variants:

      • Create antibody fragment libraries with mutations in CDR regions

      • Select for improved binding using recombinant SPAC589.09

      • Convert optimized fragments to full antibodies

    • Validate improved antibodies against native protein

  • Format Optimization for Specific Applications:

    • Generate Fab or F(ab')₂ fragments for reduced background in certain applications

    • Develop recombinant antibody formats (scFv, nanobodies) for specialized applications

    • Create fusion proteins (e.g., antibody-fluorescent protein) for direct detection

  • Validation Strategy for New Antibody Variants:

    • Compare sensitivity and specificity with original antibody

    • Test performance across multiple applications (WB, IP, IF)

    • Evaluate in knockout/overexpression systems

These approaches draw on modern antibody engineering techniques to develop reagents with improved properties for specific research applications, potentially enabling new experimental approaches to study SPAC589.09 function .

How can SPAC589.09 antibody contribute to understanding the relationship between homologous proteins in yeast and humans?

Comparative Functional Analysis Methods:

  • Homology Identification and Validation:

    • Perform bioinformatic analysis to identify human homologs (e.g., C9orf64/QNG1)

    • Compare sequence conservation, particularly in functional domains

    • Test cross-reactivity of SPAC589.09 antibody with human homologs

    • Generate specific antibodies against human counterparts

  • Complementation Studies with Antibody Validation:

    • Express human homolog in SPAC589.09 deletion strain

    • Use antibodies to confirm expression levels

    • Assess functional complementation by phenotypic analysis

    • Determine if human protein localizes similarly to yeast counterpart

  • Comparative Interactome Analysis:

    • Immunoprecipitate SPAC589.09 and human homologs from respective organisms

    • Identify interacting partners by mass spectrometry

    • Compare interaction networks for conservation and divergence

    • Validate key conserved interactions with co-immunoprecipitation

  • Structure-Function Studies:

    • Use antibodies to study the effects of targeted mutations in conserved domains

    • Compare post-translational modifications between yeast and human proteins

    • Analyze functional consequences of disrupting conserved interactions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.